NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.

Private
ShenzhenHealthcare & Life Scienceshttps://cellbri.com/

Last Round

Series B

Extension

Mar 27, 2025

Total Funding Raised

$27.58M

Company Overview

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. is a biotechnology company that develops and manufactures automated, closed, and digital cell processing systems for cell and gene therapy applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

cell and gene therapyCGTautomated cell processingclosed-system manufacturingGMP-compliant manufacturingcell therapy equipmentbioprocessing equipmentsingle-use consumablescell separationCDMObiotech manufacturinglab automationCAR-T manufacturingbiotech hardwarebenchtop bioreactor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Comparables

Compare Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Limula
88%
Sino-Biocan (Shanghai) Biotech Ltd
86%
Ori Biotech
83%

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 27, 2025
Series BJun 13, 2024
Series AOct 14, 2021
VC RoundSep 1, 2020
AngelApr 1, 2020

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Investors

Notable investors and investment history

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. investors
InvestorRounds
Beijing Chang DevelopmentSeries B, VC Round
Bencao CapitalSeries B
Delian CapitalSeries A
Changzhou Hi-tech Group Co., Ltd.Series B Extension
MPCSeries A
Tsinghua Innovation VenturesSeries B, Angel
启迪之星创投VC Round

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range18
Year Founded2020
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.